Subscribe Here!

No More “What Ifs” - How Nektar Takes the Guesswork Out of Scaling Bioprocesses

Culture's client Nektar Therapeutics is exploring new PEG-based modifications to therapeutic...

Now is the Time to Start Using a Cloud Lab

Is COVID-19 affecting your lab operations? Run bioprocess experiments from your laptop at home...

Scaling Up from Culture’s 250mL Reactors to 5,000L and 50,000L Tanks

Modern Meadow, one of Culture Biosciences’ first customers, is biomanufacturing the next...

Best Practices in Fermentation Bioprocess Development

We spoke with Stefan De Kok, Ph. D., Director of Fermentation at Zymergen, about his experience...

High-Throughput DoE Of 52 Parallel Bioreactors Doubles Titer In 1 Week

Data from an ongoing collaboration with Cytovance Biologics to rapidly optimize and scale...

Is Direct to Consumer Marketing the Key to the Success of SynBio?

We spoke with Scott Franklin, Co-Founder and CSO at Checkerspot. Checkerspot is a synthetic...

Increasing Bioprocess Productivity With Continuous Product Removal

We spoke with Kirsten Steinbusch, Ph.D, the CEO of DAB about her work in trying to make industrial...

Anaerobic Fermentation: A Breath of Fresh Air for Synthetic Biology?

We spoke with Hugo Cueto-Rojas, Ph.D., a fermentation expert who has worked on both industrial...

1